Although adverse effects may occur, selective serotonin reuptake inhibitors are generally well tolerated in the elderly

Selective serotonin reuptake inhibitors (SSRIs) have been associated with a range of adverse effects, some of which may occur more frequently in elderly patients. The increased risk of adverse SSRI-related events in this patient population may partially be due to changes in pharmacokinetics and an increased risk of drug interactions in the elderly